Share Price and Basic Stock Data
Last Updated: January 24, 2026, 5:31 pm
| PEG Ratio | 3.59 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
DMCC Speciality Chemicals Ltd operates within the specialty chemicals sector, focusing on a diverse range of chemical products. The company reported a market capitalization of ₹540 Cr and its share price stood at ₹217. Over the last few years, DMCC has experienced fluctuations in revenue, with sales reaching ₹387 Cr in the fiscal year ending March 2023, a rise from ₹326 Cr in FY 2022. However, the latest trailing twelve months (TTM) figure indicated an increase in revenue to ₹496 Cr. The quarterly sales data reflects a peak in March 2025 with ₹125.19 Cr, demonstrating a positive trend in sales recovery post-pandemic. The operating profit margin (OPM) was recorded at 11.12%, revealing a consistent ability to maintain profitability amid varying sales levels. The company’s sales strategy appears to be effective, as evidenced by the gradual recovery in sales from ₹71.91 Cr in December 2022 to ₹118.03 Cr in December 2024, indicating a rebound from lower sales periods.
Profitability and Efficiency Metrics
DMCC’s profitability metrics present a mixed picture. The net profit for the fiscal year ending March 2025 stood at ₹22 Cr, a recovery from the low of ₹7 Cr in FY 2023. The net profit margin improved to 4.99% in March 2025, up from 1.80% in March 2023. This upward trajectory suggests that the company has effectively managed its costs and improved operational efficiency. The operating profit margin (OPM) also reflected stability, reported at 13.53% for FY 2025, aligning with sector norms. In terms of efficiency, the return on equity (ROE) was noted at 9.45%, which is below the typical industry average but shows improvement from previous years. Additionally, the cash conversion cycle (CCC) stood at 37 days, indicating a reasonably efficient management of working capital. However, the company’s ability to convert sales into cash remains a critical area for enhancement, particularly as the industry tends to exhibit lower CCCs.
Balance Sheet Strength and Financial Ratios
The balance sheet of DMCC Speciality Chemicals illustrates a stable financial position. As of March 2025, total borrowings were recorded at ₹40 Cr, a significant reduction from ₹101 Cr in March 2023, indicating a concerted effort to deleverage. Reserves increased to ₹209 Cr, showcasing the company’s ability to retain earnings for future growth. The interest coverage ratio (ICR) was reported at 5.56x, signifying that the company comfortably covers its interest obligations, which is a strong indicator of financial health. The debt-to-equity ratio stood at 0.20, suggesting a conservative approach to leveraging, which is favorable for long-term sustainability. Furthermore, the price-to-book value (P/BV) ratio was 3.29x, reflecting investor confidence in the company’s growth potential relative to its book value. Overall, the financial ratios indicate a robust balance sheet with manageable debt levels and a solid capital structure.
Shareholding Pattern and Investor Confidence
The shareholding pattern of DMCC Speciality Chemicals reveals a strong promoter commitment, with promoters holding 53.84% of the equity. This level of promoter holding is generally viewed positively as it aligns their interests with those of minority shareholders. Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) held 0.39% and 1.28%, respectively, indicating limited institutional interest, which could be a point of concern regarding broader market confidence. The public shareholding stood at 44.49%, which is substantial, suggesting a healthy distribution among retail investors. The total number of shareholders was reported at 22,015, indicating a diverse ownership base. However, the slight decline in public shareholding from previous quarters may reflect some investor apprehension amidst market volatility. Overall, the current shareholding structure points towards a stable foundation, but the limited institutional participation could hinder broader market acceptance.
Outlook, Risks, and Final Insight
Looking forward, DMCC Speciality Chemicals is poised for potential growth, driven by improving sales trends and cost management strategies. However, several risks could impact its trajectory. The company faces challenges from fluctuating raw material costs and competition within the specialty chemicals sector, which could pressure margins. Additionally, the low institutional interest may limit access to capital for future expansions. Conversely, strengths such as a solid balance sheet, improving profitability, and a committed promoter base provide a strong foundation for growth. The strategic focus on operational efficiency and debt reduction enhances its resilience against market fluctuations. If DMCC can navigate these risks effectively while capitalizing on its strengths, it may continue to enhance shareholder value and position itself favorably within the specialty chemicals landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 345 Cr. | 37.5 | 71.7/36.8 | 21.4 | 20.5 | 1.07 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 28.0 Cr. | 57.0 | 88.8/55.0 | 13.4 | 89.6 | 1.75 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 44.5 Cr. | 655 | 899/600 | 20.5 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,221 Cr. | 71.0 | 111/68.2 | 21.3 | 22.0 | 0.70 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 547 Cr. | 219 | 377/213 | 19.6 | 93.8 | 1.14 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,127.48 Cr | 644.51 | 58.17 | 182.97 | 0.47% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 104.71 | 71.91 | 96.50 | 85.57 | 76.52 | 80.53 | 83.95 | 85.32 | 102.70 | 118.03 | 125.19 | 127.02 | 126.02 |
| Expenses | 101.11 | 70.83 | 80.21 | 74.60 | 66.99 | 73.41 | 76.55 | 76.47 | 87.40 | 100.29 | 110.07 | 110.14 | 112.01 |
| Operating Profit | 3.60 | 1.08 | 16.29 | 10.97 | 9.53 | 7.12 | 7.40 | 8.85 | 15.30 | 17.74 | 15.12 | 16.88 | 14.01 |
| OPM % | 3.44% | 1.50% | 16.88% | 12.82% | 12.45% | 8.84% | 8.81% | 10.37% | 14.90% | 15.03% | 12.08% | 13.29% | 11.12% |
| Other Income | 0.40 | 0.91 | 0.77 | 0.88 | 0.81 | 0.67 | 9.29 | 0.21 | 0.31 | 0.39 | 0.44 | 0.37 | 0.30 |
| Interest | 1.84 | 3.16 | 3.29 | 3.47 | 2.88 | 3.56 | 3.85 | 3.01 | 2.77 | 2.53 | 2.19 | 2.03 | 1.91 |
| Depreciation | 4.92 | 4.80 | 4.54 | 3.55 | 3.90 | 3.91 | 4.33 | 4.16 | 4.25 | 4.25 | 4.03 | 4.19 | 4.11 |
| Profit before tax | -2.76 | -5.97 | 9.23 | 4.83 | 3.56 | 0.32 | 8.51 | 1.89 | 8.59 | 11.35 | 9.34 | 11.03 | 8.29 |
| Tax % | 0.00% | -45.23% | 27.63% | 34.99% | 33.71% | 6.25% | 32.20% | 26.46% | 32.36% | 30.57% | 30.73% | 29.74% | 30.64% |
| Net Profit | -2.77 | -3.28 | 6.68 | 3.14 | 2.36 | 0.29 | 5.78 | 1.39 | 5.80 | 7.88 | 6.47 | 7.75 | 5.75 |
| EPS in Rs | -1.11 | -1.32 | 2.68 | 1.26 | 0.95 | 0.12 | 2.32 | 0.56 | 2.33 | 3.16 | 2.59 | 3.11 | 2.31 |
Last Updated: December 27, 2025, 6:03 am
Below is a detailed analysis of the quarterly data for DMCC Speciality Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 126.02 Cr.. The value appears to be declining and may need further review. It has decreased from 127.02 Cr. (Jun 2025) to 126.02 Cr., marking a decrease of 1.00 Cr..
- For Expenses, as of Sep 2025, the value is 112.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 110.14 Cr. (Jun 2025) to 112.01 Cr., marking an increase of 1.87 Cr..
- For Operating Profit, as of Sep 2025, the value is 14.01 Cr.. The value appears to be declining and may need further review. It has decreased from 16.88 Cr. (Jun 2025) to 14.01 Cr., marking a decrease of 2.87 Cr..
- For OPM %, as of Sep 2025, the value is 11.12%. The value appears to be declining and may need further review. It has decreased from 13.29% (Jun 2025) to 11.12%, marking a decrease of 2.17%.
- For Other Income, as of Sep 2025, the value is 0.30 Cr.. The value appears to be declining and may need further review. It has decreased from 0.37 Cr. (Jun 2025) to 0.30 Cr., marking a decrease of 0.07 Cr..
- For Interest, as of Sep 2025, the value is 1.91 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.03 Cr. (Jun 2025) to 1.91 Cr., marking a decrease of 0.12 Cr..
- For Depreciation, as of Sep 2025, the value is 4.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.19 Cr. (Jun 2025) to 4.11 Cr., marking a decrease of 0.08 Cr..
- For Profit before tax, as of Sep 2025, the value is 8.29 Cr.. The value appears to be declining and may need further review. It has decreased from 11.03 Cr. (Jun 2025) to 8.29 Cr., marking a decrease of 2.74 Cr..
- For Tax %, as of Sep 2025, the value is 30.64%. The value appears to be increasing, which may not be favorable. It has increased from 29.74% (Jun 2025) to 30.64%, marking an increase of 0.90%.
- For Net Profit, as of Sep 2025, the value is 5.75 Cr.. The value appears to be declining and may need further review. It has decreased from 7.75 Cr. (Jun 2025) to 5.75 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.31. The value appears to be declining and may need further review. It has decreased from 3.11 (Jun 2025) to 2.31, marking a decrease of 0.80.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:50 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 101 | 120 | 108 | 175 | 178 | 227 | 188 | 200 | 326 | 387 | 328 | 431 | 496 |
| Expenses | 86 | 101 | 91 | 145 | 155 | 174 | 160 | 165 | 286 | 351 | 292 | 374 | 433 |
| Operating Profit | 15 | 20 | 16 | 30 | 23 | 53 | 28 | 36 | 41 | 36 | 36 | 57 | 64 |
| OPM % | 15% | 16% | 15% | 17% | 13% | 24% | 15% | 18% | 12% | 9% | 11% | 13% | 13% |
| Other Income | 6 | -1 | 0 | 1 | 1 | 1 | 6 | 8 | 6 | 3 | 10 | 1 | 2 |
| Interest | 2 | 2 | 1 | 5 | 4 | 3 | 2 | 2 | 5 | 11 | 14 | 10 | 9 |
| Depreciation | 3 | 2 | 2 | 4 | 4 | 5 | 6 | 7 | 8 | 18 | 16 | 17 | 17 |
| Profit before tax | 16 | 14 | 13 | 21 | 16 | 47 | 26 | 34 | 34 | 10 | 17 | 31 | 40 |
| Tax % | 0% | 0% | 9% | 21% | 21% | 2% | -22% | 4% | 37% | 35% | 33% | 31% | |
| Net Profit | 16 | 14 | 12 | 17 | 12 | 46 | 31 | 33 | 21 | 7 | 12 | 22 | 28 |
| EPS in Rs | 7.55 | 6.58 | 5.63 | 7.79 | 4.92 | 18.47 | 12.63 | 13.06 | 8.56 | 2.75 | 4.64 | 8.64 | 11.17 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 10% | 8% | 0% | 15% | 6% | 0% | 22% | 29% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -12.50% | -14.29% | 41.67% | -29.41% | 283.33% | -32.61% | 6.45% | -36.36% | -66.67% | 71.43% | 83.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1.79% | 55.95% | -71.08% | 312.75% | -315.94% | 39.06% | -42.82% | -30.30% | 138.10% | 11.90% |
DMCC Speciality Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 18% |
| 3 Years: | 10% |
| TTM: | 45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | -7% |
| 3 Years: | 1% |
| TTM: | 184% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 14% |
| 3 Years: | -8% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 9% |
| 3 Years: | 5% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 3:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:46 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 21 | 21 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | -13 | 1 | 13 | 35 | 48 | 91 | 120 | 148 | 168 | 173 | 184 | 202 | 209 |
| Borrowings | 38 | 35 | 27 | 30 | 25 | 22 | 25 | 35 | 93 | 101 | 88 | 72 | 40 |
| Other Liabilities | 53 | 32 | 34 | 59 | 59 | 51 | 42 | 55 | 97 | 101 | 80 | 81 | 101 |
| Total Liabilities | 99 | 88 | 94 | 149 | 156 | 188 | 212 | 263 | 383 | 400 | 377 | 380 | 374 |
| Fixed Assets | 26 | 24 | 26 | 83 | 87 | 99 | 101 | 108 | 174 | 230 | 238 | 234 | 226 |
| CWIP | 1 | 1 | 5 | 3 | 3 | 1 | 9 | 38 | 63 | 11 | 6 | 0 | 0 |
| Investments | 0 | 0 | 0 | 2 | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 72 | 63 | 63 | 60 | 62 | 86 | 98 | 116 | 146 | 159 | 132 | 145 | 147 |
| Total Assets | 99 | 88 | 94 | 149 | 156 | 188 | 212 | 263 | 383 | 400 | 377 | 380 | 374 |
Below is a detailed analysis of the balance sheet data for DMCC Speciality Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
- For Reserves, as of Sep 2025, the value is 209.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Mar 2025) to 209.00 Cr., marking an increase of 7.00 Cr..
- For Borrowings, as of Sep 2025, the value is 40.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 72.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 32.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 101.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81.00 Cr. (Mar 2025) to 101.00 Cr., marking an increase of 20.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 374.00 Cr.. The value appears to be improving (decreasing). It has decreased from 380.00 Cr. (Mar 2025) to 374.00 Cr., marking a decrease of 6.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 226.00 Cr.. The value appears to be declining and may need further review. It has decreased from 234.00 Cr. (Mar 2025) to 226.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 147.00 Cr.. The value appears strong and on an upward trend. It has increased from 145.00 Cr. (Mar 2025) to 147.00 Cr., marking an increase of 2.00 Cr..
- For Total Assets, as of Sep 2025, the value is 374.00 Cr.. The value appears to be declining and may need further review. It has decreased from 380.00 Cr. (Mar 2025) to 374.00 Cr., marking a decrease of 6.00 Cr..
Notably, the Reserves (209.00 Cr.) exceed the Borrowings (40.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -23.00 | -15.00 | -11.00 | 0.00 | -2.00 | 31.00 | 3.00 | 1.00 | -52.00 | -65.00 | -52.00 | -15.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 44 | 44 | 45 | 45 | 48 | 48 | 58 | 56 | 49 | 51 | 63 |
| Inventory Days | 52 | 62 | 104 | 60 | 73 | 80 | 113 | 151 | 79 | 78 | 81 | 58 |
| Days Payable | 126 | 76 | 115 | 129 | 114 | 79 | 68 | 116 | 131 | 121 | 119 | 84 |
| Cash Conversion Cycle | -12 | 29 | 33 | -25 | 4 | 49 | 93 | 94 | 3 | 6 | 13 | 37 |
| Working Capital Days | 15 | 1 | -7 | -37 | -6 | 43 | 80 | 32 | -5 | 2 | 5 | 16 |
| ROCE % | 34% | 34% | 24% | 35% | 21% | 43% | 18% | 19% | 16% | 7% | 8% | 14% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| Diluted EPS (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| Cash EPS (Rs.) | 15.34 | 10.95 | 9.84 | 11.79 | 15.80 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.25 | 84.02 | 79.49 | 77.64 | 69.44 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.25 | 84.02 | 79.49 | 77.64 | 69.44 |
| Revenue From Operations / Share (Rs.) | 172.93 | 131.50 | 154.26 | 130.83 | 80.25 |
| PBDIT / Share (Rs.) | 23.40 | 18.73 | 15.55 | 18.48 | 17.35 |
| PBIT / Share (Rs.) | 16.70 | 12.43 | 8.49 | 15.25 | 14.61 |
| PBT / Share (Rs.) | 12.48 | 6.92 | 4.25 | 13.69 | 13.65 |
| Net Profit / Share (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| NP After MI And SOA / Share (Rs.) | 8.63 | 4.65 | 2.78 | 8.56 | 13.06 |
| PBDIT Margin (%) | 13.53 | 14.24 | 10.07 | 14.12 | 21.61 |
| PBIT Margin (%) | 9.65 | 9.45 | 5.50 | 11.65 | 18.20 |
| PBT Margin (%) | 7.21 | 5.26 | 2.75 | 10.46 | 17.00 |
| Net Profit Margin (%) | 4.99 | 3.53 | 1.80 | 6.54 | 16.27 |
| NP After MI And SOA Margin (%) | 4.99 | 3.53 | 1.80 | 6.54 | 16.27 |
| Return on Networth / Equity (%) | 9.45 | 5.53 | 3.49 | 11.02 | 18.81 |
| Return on Capital Employeed (%) | 15.38 | 11.47 | 7.88 | 15.10 | 18.68 |
| Return On Assets (%) | 5.66 | 3.07 | 1.72 | 5.56 | 12.35 |
| Long Term Debt / Equity (X) | 0.17 | 0.27 | 0.34 | 0.28 | 0.09 |
| Total Debt / Equity (X) | 0.20 | 0.31 | 0.40 | 0.40 | 0.14 |
| Asset Turnover Ratio (%) | 1.14 | 0.84 | 0.98 | 1.01 | 0.84 |
| Current Ratio (X) | 1.23 | 1.08 | 1.04 | 0.95 | 1.68 |
| Quick Ratio (X) | 0.84 | 0.66 | 0.63 | 0.64 | 1.13 |
| Inventory Turnover Ratio (X) | 9.95 | 4.03 | 5.48 | 5.09 | 2.94 |
| Dividend Payout Ratio (NP) (%) | 11.58 | 0.00 | 35.98 | 5.84 | 11.68 |
| Dividend Payout Ratio (CP) (%) | 6.52 | 0.00 | 10.16 | 4.24 | 9.65 |
| Earning Retention Ratio (%) | 88.42 | 0.00 | 64.02 | 94.16 | 88.32 |
| Cash Earning Retention Ratio (%) | 93.48 | 0.00 | 89.84 | 95.76 | 90.35 |
| Interest Coverage Ratio (X) | 5.56 | 3.40 | 3.67 | 11.84 | 18.03 |
| Interest Coverage Ratio (Post Tax) (X) | 3.05 | 1.84 | 1.66 | 6.48 | 14.57 |
| Enterprise Value (Cr.) | 789.57 | 745.75 | 677.05 | 982.66 | 815.55 |
| EV / Net Operating Revenue (X) | 1.83 | 2.27 | 1.76 | 3.01 | 4.07 |
| EV / EBITDA (X) | 13.53 | 15.96 | 17.46 | 21.32 | 18.85 |
| MarketCap / Net Operating Revenue (X) | 1.74 | 2.09 | 1.56 | 2.78 | 3.96 |
| Retention Ratios (%) | 88.41 | 0.00 | 64.01 | 94.15 | 88.31 |
| Price / BV (X) | 3.29 | 3.27 | 3.02 | 4.69 | 4.58 |
| Price / Net Operating Revenue (X) | 1.74 | 2.09 | 1.56 | 2.78 | 3.96 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.02 | 0.04 |
After reviewing the key financial ratios for DMCC Speciality Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For Cash EPS (Rs.), as of Mar 25, the value is 15.34. This value is within the healthy range. It has increased from 10.95 (Mar 24) to 15.34, marking an increase of 4.39.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 172.93. It has increased from 131.50 (Mar 24) to 172.93, marking an increase of 41.43.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 23.40. This value is within the healthy range. It has increased from 18.73 (Mar 24) to 23.40, marking an increase of 4.67.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.70. This value is within the healthy range. It has increased from 12.43 (Mar 24) to 16.70, marking an increase of 4.27.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.48. This value is within the healthy range. It has increased from 6.92 (Mar 24) to 12.48, marking an increase of 5.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
- For PBDIT Margin (%), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 14.24 (Mar 24) to 13.53, marking a decrease of 0.71.
- For PBIT Margin (%), as of Mar 25, the value is 9.65. This value is below the healthy minimum of 10. It has increased from 9.45 (Mar 24) to 9.65, marking an increase of 0.20.
- For PBT Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 10. It has increased from 5.26 (Mar 24) to 7.21, marking an increase of 1.95.
- For Net Profit Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 5. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 8. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.45. This value is below the healthy minimum of 15. It has increased from 5.53 (Mar 24) to 9.45, marking an increase of 3.92.
- For Return on Capital Employeed (%), as of Mar 25, the value is 15.38. This value is within the healthy range. It has increased from 11.47 (Mar 24) to 15.38, marking an increase of 3.91.
- For Return On Assets (%), as of Mar 25, the value is 5.66. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 5.66, marking an increase of 2.59.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has decreased from 0.27 (Mar 24) to 0.17, marking a decrease of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.31 (Mar 24) to 0.20, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has increased from 0.84 (Mar 24) to 1.14, marking an increase of 0.30.
- For Current Ratio (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 24) to 1.23, marking an increase of 0.15.
- For Quick Ratio (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.84, marking an increase of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.95. This value exceeds the healthy maximum of 8. It has increased from 4.03 (Mar 24) to 9.95, marking an increase of 5.92.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.58. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 11.58, marking an increase of 11.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.52. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 6.52, marking an increase of 6.52.
- For Earning Retention Ratio (%), as of Mar 25, the value is 88.42. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 88.42, marking an increase of 88.42.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.48. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 93.48, marking an increase of 93.48.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 5.56. This value is within the healthy range. It has increased from 3.40 (Mar 24) to 5.56, marking an increase of 2.16.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.05. This value is within the healthy range. It has increased from 1.84 (Mar 24) to 3.05, marking an increase of 1.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 789.57. It has increased from 745.75 (Mar 24) to 789.57, marking an increase of 43.82.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 2.27 (Mar 24) to 1.83, marking a decrease of 0.44.
- For EV / EBITDA (X), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 15.96 (Mar 24) to 13.53, marking a decrease of 2.43.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
- For Retention Ratios (%), as of Mar 25, the value is 88.41. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 88.41, marking an increase of 88.41.
- For Price / BV (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 3. It has increased from 3.27 (Mar 24) to 3.29, marking an increase of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DMCC Speciality Chemicals Ltd:
- Net Profit Margin: 4.99%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 15.38% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.45% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.05
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.84
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 19.6 (Industry average Stock P/E: 58.17)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.2
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.99%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Prospect Chambers, 317/321, Dr. Dadabhoy Naoroji Road, Mumbai Maharashtra 400001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Laxmikumar Narottam Goculdas | Chairman |
| Ms. Mitika Laxmikumar Goculdas | Vice Chairperson |
| Mr. Bimal Lalitsingh Goculdas | Managing Director & CEO |
| Mr. Kuldeep Kumar Tiwari | Executive Director - Operations |
| Mr. Mukul Manoharlal Taly | Ind. Non-Executive Director |
| Mr. Sanjeev Vishwanath Joshi | Ind. Non-Executive Director |
| Dr.(Mrs.) Janaki Ashwin Patwardhan | Ind. Non-Executive Director |
| Mr. Haren Devidas Parekh | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of DMCC Speciality Chemicals Ltd?
DMCC Speciality Chemicals Ltd's intrinsic value (as of 27 January 2026) is ₹156.42 which is 28.58% lower the current market price of ₹219.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹547 Cr. market cap, FY2025-2026 high/low of ₹377/213, reserves of ₹209 Cr, and liabilities of ₹374 Cr.
What is the Market Cap of DMCC Speciality Chemicals Ltd?
The Market Cap of DMCC Speciality Chemicals Ltd is 547 Cr..
What is the current Stock Price of DMCC Speciality Chemicals Ltd as on 27 January 2026?
The current stock price of DMCC Speciality Chemicals Ltd as on 27 January 2026 is ₹219.
What is the High / Low of DMCC Speciality Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of DMCC Speciality Chemicals Ltd stocks is ₹377/213.
What is the Stock P/E of DMCC Speciality Chemicals Ltd?
The Stock P/E of DMCC Speciality Chemicals Ltd is 19.6.
What is the Book Value of DMCC Speciality Chemicals Ltd?
The Book Value of DMCC Speciality Chemicals Ltd is 93.8.
What is the Dividend Yield of DMCC Speciality Chemicals Ltd?
The Dividend Yield of DMCC Speciality Chemicals Ltd is 1.14 %.
What is the ROCE of DMCC Speciality Chemicals Ltd?
The ROCE of DMCC Speciality Chemicals Ltd is 14.1 %.
What is the ROE of DMCC Speciality Chemicals Ltd?
The ROE of DMCC Speciality Chemicals Ltd is 9.97 %.
What is the Face Value of DMCC Speciality Chemicals Ltd?
The Face Value of DMCC Speciality Chemicals Ltd is 10.0.